Immediate Impact
64 standout
Citing Papers
Targeting ROS in cancer: rationale and strategies
2024 Standout
Trials and Tribulations of MicroRNA Therapeutics
2024 Standout
Works of Derek Xu being referenced
Isorhapontigenin suppresses growth of patient-derived glioblastoma spheres through regulating miR-145/SOX2/cyclin D1 axis
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Derek Xu | 176 | 33 | 19 | 50 | 48 | 12 | 252 | |
| Haoyan Ji | 129 | 18 | 12 | 44 | 41 | 13 | 232 | |
| Yibiao Chen | 159 | 19 | 13 | 50 | 58 | 14 | 268 | |
| Marco Coazzoli | 150 | 37 | 10 | 52 | 39 | 10 | 296 | |
| Shaofeng Wang | 162 | 26 | 9 | 105 | 46 | 18 | 298 | |
| Prosanta Singha | 177 | 64 | 15 | 41 | 30 | 10 | 276 | |
| Hélène Hernandez-Pigeon | 107 | 27 | 9 | 43 | 33 | 10 | 256 | |
| Long Ding | 127 | 23 | 29 | 22 | 47 | 13 | 241 | |
| Marine Malleter | 202 | 29 | 5 | 54 | 54 | 10 | 280 | |
| Zeeshan Shaukat | 141 | 51 | 44 | 52 | 43 | 20 | 240 | |
| Alfredo Sagredo | 182 | 49 | 9 | 21 | 42 | 11 | 280 |
All Works
Login with ORCID to disown or claim papers
Loading papers...